库欣病患者总体及疾病特异性死亡率:瑞典全国性研究
该回顾性全国队列研究纳入1987至2013年瑞典国家患者登记中502例库欣病患者,系统复核病历确认诊断,计算标准化死亡比(SMR)并用Cox回归分析死亡预测因素。结果显示总体SMR为2.5(95%CI 2.1-2.9),心血管疾病为最常见死因(SMR 3.3),感染和自杀亦存在超额死亡;缓解患者SMR为1.9,双侧肾上腺切除术和糖皮质激素替代治疗与死亡率增加独立相关,而生长激素替代与结局改善相关。
要点
- 库欣病患者总体死亡率显著增加,SMR为2.5,心血管疾病为主要死因。
- 即使达到缓解,患者死亡率仍高于一般人群,SMR为1.9。
- 双侧肾上腺切除术和糖皮质激素替代治疗与死亡率增加独立相关。
核心结论
- 库欣病患者存在超额死亡率,即使达到缓解死亡率仍高于一般人群。
- 心血管疾病是最常见死因,感染和自杀亦与超额死亡相关。
研究设计与样本
- 回顾性全国性队列研究,纳入瑞典国家患者登记1987至2013年诊断的502例库欣病患者(女性387例,占77%)。
- 系统复核病历验证诊断,419例(83%)确认缓解;诊断时平均年龄43岁(SD 16),中位随访13年(IQR 6-23)。
主要发现
- 观察死亡133例,预期54例,总体SMR为2.5(95%CI 2.1-2.9)。
- 心血管疾病SMR为3.3(95%CI 2.6-4.3),为最常见死因。
- 感染和自杀亦存在超额死亡。
- 缓解患者SMR为1.9(95%CI 1.5-2.3)。
- 双侧肾上腺切除术和糖皮质激素替代治疗与死亡率增加独立相关,生长激素替代与结局改善相关。
临床怎么用
- 应重视库欣病患者达到缓解,并持续主动监测。
- 需充分评估心血管风险和精神健康,并给予适当的激素替代治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Whether patients with Cushing disease (CD) in remission have increased mortality is still debatable. OBJECTIVE: To study overall and disease-specific mortality and predictive factors in an unselected nationwide cohort of patients with CD. DESIGN, PATIENTS, AND METHODS: A retrospective study of patients diagnosed with CD, identified in the Swedish National Patient Registry between 1987 and 2013. Medical records were systematically reviewed to verify the diagnosis. Standardized mortality ratios (SMRs) with 95% CIs were calculated and Cox regression models were used to identify predictors of mortality. RESULTS: Of 502 identified patients with CD (n = 387 women; 77%), 419 (83%) were confirmed to be in remission. Mean age at diagnosis was 43 (SD, 16) years and median follow-up was 13 (interquartile range, 6 to 23) years. The observed number of deaths was 133 vs 54 expected, resulting in an overall SMR of 2.5 (95% CI, 2.1 to 2.9). The commonest cause of death was cardiovascular diseases (SMR, 3.3; 95% CI, 2.6 to 4.3). Excess mortality was also found associated with infections and suicide. For patients in remission, the SMR was 1.9 (95% CI, 1.5 to 2.3); bilateral adrenalectomy and glucocorticoid replacement therapy were independently associated with increased mortality, whereas GH replacement was associated with improved outcome. CONCLUSION: Findings from this large nationwide study indicate that patients with CD have excess mortality. The findings illustrate the importance of achieving remission and continued active surveillance, along with adequate hormone replacement and evaluation of cardiovascular risk and mental health.
引用
- Ragnarsson O, Olsson DS, Papakokkinou E, et al. Overall and Disease-Specific Mortality in Patients With Cushing Disease: A Swedish Nationwide Study. J Clin Endocrinol Metab. 2019. PMID: 30715394. doi:10.1210/jc.2018-02524
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。